Last update 05 Jul 2025

MPER-656 liposome vaccine(National Institute of Allergy & Infectious Diseases)

Overview

Basic Info

Drug Type
Therapeutic vaccine, Liposomal Drug
Synonyms
MPER-656
Target
gp41
Action
inhibitors
Mechanism
gp41 inhibitors(Transmembrane glycoprotein gp41 inhibitors)
Therapeutic Areas-
Active Indication-
Inactive Indication-
Originator Organization
National Institute of Allergy & Infectious Diseases
Active Organization-
Inactive Organization
National Institute of Allergy & Infectious Diseases
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with MPER-656 liposome vaccine(National Institute of Allergy & Infectious Diseases)
NCT03934541
/ CompletedPhase 1IIT
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult Participants
100 Clinical Results associated with MPER-656 liposome vaccine(National Institute of Allergy & Infectious Diseases)
Login to view more data
100 Translational Medicine associated with MPER-656 liposome vaccine(National Institute of Allergy & Infectious Diseases)
Login to view more data
100 Patents (Medical) associated with MPER-656 liposome vaccine(National Institute of Allergy & Infectious Diseases)
Login to view more data
100 Deals associated with MPER-656 liposome vaccine(National Institute of Allergy & Infectious Diseases)
Login to view more data

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT03934541 (CTgov)
Phase 1
HIV Infections
24
(Treatment 1: 500 mcg MPER-656 mo(0,2,6,12))
lvfhupspsm(qfsnsnqzqc) = pemafctord duboxhuxlt (glyrhzdxyt, pfurypmijd - rrjdxfhgjm)
View more
-
12 May 2022
(Treatment 2: 2000 mcg MPER-656 mo(0,2,6,12))
lvfhupspsm(qfsnsnqzqc) = hglskekyti duboxhuxlt (glyrhzdxyt, dbwjlmrcuq - clynhyxskp)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free